Skip to main content
SABS logo

SABS

SAB Biotherapeutics, Inc.
$3.77 -0.13 (-3.33%) At close · Jul 8
Market Cap
$302.80M
Shares
76,464,094

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 79
Total Value: $296,277,279
Total Shares: 77,357,001

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 79 13F filers · Δ vs Dec 31, 2025
Top Holder
16.5%
Dec 2023 → Mar 2026 · range 16.5% – 52.2%
−15.0 pts
Top 5
49.9%
Dec 2023 → Mar 2026 · range 49.9% – 100.0%
−19.7 pts
Top 10
72.3%
Dec 2023 → Mar 2026 · range 72.3% – 100.0%
−18.4 pts
HHI
717
Dec 2023 → Mar 2026 · range 717 – 3,884
Broadly held−779

Quarterly Activity

vs Dec 31, 2025
New
37
Increased
24
Decreased
7
Sold Out
5
Unchanged
11
Holder count: +32
Institutional value: +118.3%
Shares held: +113.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 83 of 83
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1833214 CUSIP 78397T202 Visit website Investor relations